As a company, science and innovation are our collective inspiration. The speed and energy being generated are moving our industry into pioneering new areas. We want to use this momentum to accelerate the pace at which we share our research and perspectives on Tobacco Harm Reduction, and help adult smokers make informed choices when it comes to switching to less risky* alternatives.
Our R&D teams are central to our Tobacco Harm Reduction efforts around the world.
We’re committed to reducing the health impact of our business by offering consumers a greater choice of enjoyable and less risky* products. We operate in the three main categories: vapour products, tobacco heating products, and modern oral products.
It is widely accepted that most of the harm associated with tobacco is caused by inhaling the smoke produced by its combustion — not by nicotine.
We know that consumers’ preferences, tastes, and behaviours are continually evolving, and our experts are constantly innovating to meet the demand.
Our proprietary, fast-growing plant-based technology is being used to develop a potential vaccine against COVID-19.